Chinese SDA (State Drug Administration) gets EU regulatory update:
This article was originally published in Clinica
Executive Summary
The latest regulatory developments in the EU and China will be on the agenda when officials from the Chinese State Drug Administration visit the European device industry association, Eucomed, on September 19-20 2002. The Chinese delegation, led by SDA medical devices registration division director Chang Yongheng, will also meet DG Enterprise officials, UK notified body BSI and the MDA during their brief tour. The Chinese medial devices market is valued by the US Department of Commerce at $5.2bn, $1.4bn of which (in 2000) was provided by imports. Imports grew by 15.5% that year, says Eucomed.